Iijima, Kazumoto
Nozu, Kandai
Article History
First Online: 15 October 2018
Compliance with Ethical Standards
:
: Dr. Nozu reports personal fees from Asahi Kasei Pharma Corporation, personal fees from Chugai Pharmaceutical Co., Ltd., outside the submitted work;Dr. Iijima reports grants from Zenyaku Kogyo Co., Ltd., during the conduct of the study; grants and personal fees from Novartis Pharma K.K.; grants from Japan Blood Product Organization; grants from AbbVie LLC; grants and personal fees from JCR Pharmaceuticals Co., Ltd.; grants from Daiichi Sankyo, Co., Ltd.; grants from Teijin Pharma Ltd.; grants from CSL Behring; grants from Novo Nordisk Pharma Ltd.; grants from Air Water Medical Inc.; grants and personal fees from Astellas Pharma Inc.; grants and personal fees from Takeda Pharmaceutical Co., Ltd.; grants from Taisho Toyama Pharmaceutical Co., Ltd.; grants from Eisai Co. Ltd.; personal fees from Zenyaku Kogyo Co., Ltd.; personal fees from Chugai Pharmaceutical Co., Ltd.; personal fees from Kyowa Hakko Kirin Co., Ltd.; personal fees from Ono Pharmaceutical Co., Ltd.; personal fees from Springer Japan KK.; personal fees from Meiji Seika Pharma Co., Ltd.; personal fees from Asahi kasei Pharma Corporation; personal fees from Medical Review Co., Ltd.; personal fees from Nippon Boehringer Ingelheim Co., Ltd.; personal fees from Baxter Limited; personal fees from Sanwa Kagaku Kenkyusho Co., Ltd.; personal fees from Sanofi K.K.; and personal fees from Alexion Pharma LLC., outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.